JP2008523084A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008523084A5 JP2008523084A5 JP2007545629A JP2007545629A JP2008523084A5 JP 2008523084 A5 JP2008523084 A5 JP 2008523084A5 JP 2007545629 A JP2007545629 A JP 2007545629A JP 2007545629 A JP2007545629 A JP 2007545629A JP 2008523084 A5 JP2008523084 A5 JP 2008523084A5
- Authority
- JP
- Japan
- Prior art keywords
- tlr8
- immunostimulatory
- combination
- oligonucleotide
- biological activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000003308 immunostimulating effect Effects 0.000 claims 15
- 108091034117 Oligonucleotide Proteins 0.000 claims 10
- 229940124614 TLR 8 agonist Drugs 0.000 claims 8
- 101000800483 Homo sapiens Toll-like receptor 8 Proteins 0.000 claims 6
- 102100033110 Toll-like receptor 8 Human genes 0.000 claims 6
- 230000004071 biological effect Effects 0.000 claims 6
- 230000001404 mediated effect Effects 0.000 claims 6
- WSIZDLIFQIDDKA-UHFFFAOYSA-N 3h-imidazo[4,5-h]quinolin-2-amine Chemical class C1=CC=NC2=C(NC(N)=N3)C3=CC=C21 WSIZDLIFQIDDKA-UHFFFAOYSA-N 0.000 claims 4
- 230000001939 inductive effect Effects 0.000 claims 3
- JWLAFIOGOBJKEP-UHFFFAOYSA-N 1h-imidazo[4,5-b][1,8]naphthyridin-2-amine Chemical compound C1=CN=C2NC3=NC(N)=NC3=CC2=C1 JWLAFIOGOBJKEP-UHFFFAOYSA-N 0.000 claims 2
- KXQPVJRJUJJWQJ-UHFFFAOYSA-N 1h-imidazo[4,5-b]pyridin-2-amine Chemical class C1=CN=C2NC(N)=NC2=C1 KXQPVJRJUJJWQJ-UHFFFAOYSA-N 0.000 claims 2
- MJEPPEQNLZSPAP-UHFFFAOYSA-N 1h-pyrazolo[4,3-b]pyridin-3-amine Chemical compound C1=CN=C2C(N)=NNC2=C1 MJEPPEQNLZSPAP-UHFFFAOYSA-N 0.000 claims 2
- VIIYMKOWLFKDHA-UHFFFAOYSA-N 2,3,3a,4-tetrahydro-1h-imidazo[4,5-b][1,8]naphthyridin-2-amine Chemical compound N1C2=NC=CC=C2C=C2C1NC(N)N2 VIIYMKOWLFKDHA-UHFFFAOYSA-N 0.000 claims 2
- BZBQNDWAMYFNIE-UHFFFAOYSA-N 2,3,3a,4-tetrahydro-1h-imidazo[4,5-h]quinolin-2-amine Chemical class C1C=C2C=CC=NC2=C2C1NC(N)N2 BZBQNDWAMYFNIE-UHFFFAOYSA-N 0.000 claims 2
- SAJBWRVUKZNQOE-UHFFFAOYSA-N 2,3,4,7-tetrahydro-1H-pyrazolo[3,4-h]quinolin-2-amine Chemical compound N1C(CCC2=CC=C3C(=C12)C=NN3)N SAJBWRVUKZNQOE-UHFFFAOYSA-N 0.000 claims 2
- GXMQWVODCKZRCU-UHFFFAOYSA-N C1=CC2=NN=CC2=C2NC(N)=CC=C21 Chemical compound C1=CC2=NN=CC2=C2NC(N)=CC=C21 GXMQWVODCKZRCU-UHFFFAOYSA-N 0.000 claims 2
- KJKUZLNQTQDSSM-UHFFFAOYSA-N N1=NC(=C2C1=CC=1C=CC=NC=1N2)N Chemical compound N1=NC(=C2C1=CC=1C=CC=NC=1N2)N KJKUZLNQTQDSSM-UHFFFAOYSA-N 0.000 claims 2
- QOOXNMYDCWUEHW-UHFFFAOYSA-N [1,3]oxazolo[4,5-h]quinolin-2-amine Chemical compound C1=CC=NC2=C(OC(N)=N3)C3=CC=C21 QOOXNMYDCWUEHW-UHFFFAOYSA-N 0.000 claims 2
- YUDGNSDTJOJYBS-UHFFFAOYSA-N [1,3]oxazolo[5,4-b][1,8]naphthyridin-2-amine Chemical compound C1=CN=C2N=C(OC(N)=N3)C3=CC2=C1 YUDGNSDTJOJYBS-UHFFFAOYSA-N 0.000 claims 2
- YSQNOJMVGVZJRJ-UHFFFAOYSA-N [1,3]oxazolo[5,4-b]pyridin-2-amine Chemical compound C1=CN=C2OC(N)=NC2=C1 YSQNOJMVGVZJRJ-UHFFFAOYSA-N 0.000 claims 2
- OAQXNSYLSGLERW-UHFFFAOYSA-N 2,3,3a,4-tetrahydro-1h-pyrazolo[4,3-b][1,8]naphthyridin-3-amine Chemical compound C1=CN=C2NC3C(N)NNC3=CC2=C1 OAQXNSYLSGLERW-UHFFFAOYSA-N 0.000 claims 1
- 230000002195 synergetic effect Effects 0.000 claims 1
Claims (5)
- 免疫賦活性オリゴヌクレオチドと組み合わせて、少なくとも1種のTLR8介在性生物活性を誘導することが可能である量のTLR8アゴニスト;および
TLR8アゴニストが少なくとも1種のTLR8介在性生物活性を誘導する程度を増大させるのに有効な量の免疫賦活性オリゴヌクレオチド
を含む免疫賦活用合剤であって、
TLR8アゴニストが、置換されたイミダゾキノリンアミン、テトラヒドロイミダゾキノリンアミン、イミダゾピリジンアミン、1,2−架橋イミダゾキノリンアミン、6,7−縮合シクロアルキルイミダゾピリジンアミン、イミダゾナフチリジンアミン、テトラヒドロイミダゾナフチリジンアミン、オキサゾロキノリンアミン、チアゾロキノリンアミン、オキサゾロピリジンアミン、チアゾロピリジンアミン、オキサゾロナフチリジンアミン、チアゾロナフチリジンアミン、ピラゾロピリジンアミン、ピラゾロキノリンアミン、テトラヒドロピラゾロキノリンアミン、ピラゾロナフチリジンアミン、またはテトラヒドロピラゾロナフチリジンアミンを含む、前記免疫賦活用合剤。 - 免疫賦活性オリゴヌクレオチドが、CpGオリゴジヌクレオチドを含む、請求項1に記載の免疫賦活用合剤。
- 免疫賦活性オリゴヌクレオチドと組み合わせて、少なくとも1種のTLR8介在性生物活性を誘導することが可能である量のTLR8アゴニスト;および
TLR8アゴニストが少なくとも1種のTLR8介在性生物活性を誘導する程度を増大させるのに有効な量の免疫賦活性オリゴヌクレオチド
を含む免疫賦活用合剤であって、
免疫賦活性オリゴヌクレオチドが、CpGオリゴヌクレオチド以外のオリゴヌクレオチドを含む、前記免疫賦活用合剤。 - TLR8アゴニストが、イミダゾキノリンアミン、テトラヒドロイミダゾキノリンアミン、イミダゾピリジンアミン、1,2−架橋イミダゾキノリンアミン、6,7−縮合シクロアルキルイミダゾピリジンアミン、イミダゾナフチリジンアミン、テトラヒドロイミダゾナフチリジンアミン、オキサゾロキノリンアミン、チアゾロキノリンアミン、オキサゾロピリジンアミン、チアゾロピリジンアミン、オキサゾロナフチリジンアミン、チアゾロナフチリジンアミン、ピラゾロピリジンアミン、ピラゾロキノリンアミン、テトラヒドロピラゾロキノリンアミン、ピラゾロナフチリジンアミン、またはテトラヒドロピラゾロナフチリジンアミンを含む、請求項3に記載の免疫賦活用合剤。
- 免疫賦活性オリゴヌクレオチドと組み合わせて、少なくとも1種のTLR8介在性生物活性を誘導することが可能である量のTLR8アゴニスト;および
TLR8アゴニストによって誘導される少なくとも1種のTLR8介在性生物活性の相乗作用的な増大を提供するのに有効な量の免疫賦活性オリゴヌクレオチド
を含む、前記免疫賦活用合剤。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63414604P | 2004-12-08 | 2004-12-08 | |
PCT/US2005/044448 WO2006063152A2 (en) | 2004-12-08 | 2005-12-08 | Immunostimulatory combinations and methods |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008523084A JP2008523084A (ja) | 2008-07-03 |
JP2008523084A5 true JP2008523084A5 (ja) | 2009-01-29 |
Family
ID=36578582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007545629A Withdrawn JP2008523084A (ja) | 2004-12-08 | 2005-12-08 | 免疫賦活用合剤および方法 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20100113565A1 (ja) |
EP (1) | EP1819226A4 (ja) |
JP (1) | JP2008523084A (ja) |
WO (1) | WO2006063152A2 (ja) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE378348T1 (de) * | 2000-01-14 | 2007-11-15 | Us Health | Oligodeoxynukleotide und ihre verwendung zur induktion einer immunreaktion |
US20040265351A1 (en) | 2003-04-10 | 2004-12-30 | Miller Richard L. | Methods and compositions for enhancing immune response |
EP1653914A4 (en) | 2003-08-12 | 2008-10-29 | 3M Innovative Properties Co | COMPOUNDS CONTAINING OXIME SUBSTITUTED IMIDAZO STRUCTURE |
NZ545412A (en) | 2003-08-27 | 2008-12-24 | Coley Pharm Group Inc | Aryloxy and arylalkyleneoxy substituted imidazoquinolines |
CA2537763A1 (en) | 2003-09-05 | 2005-03-17 | 3M Innovative Properties Company | Treatment for cd5+ b cell lymphoma |
BRPI0414867A (pt) | 2003-10-03 | 2006-11-21 | 3M Innovative Properties Co | pirazolopiridinas e seus análogos |
BRPI0414856A (pt) | 2003-10-03 | 2006-11-21 | 3M Innovative Properties Co | imidazoquinolinas alcóxi-substituìdas |
US7544697B2 (en) | 2003-10-03 | 2009-06-09 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and analogs thereof |
CN1906193A (zh) | 2003-11-14 | 2007-01-31 | 3M创新有限公司 | 肟取代的咪唑环化合物 |
CA2545825A1 (en) | 2003-11-14 | 2005-06-02 | 3M Innovative Properties Company | Hydroxylamine substituted imidazo ring compounds |
MXPA06005910A (es) | 2003-11-25 | 2006-08-23 | 3M Innovative Properties Co | Sistemas de anillo imidazo sustituido y metodos. |
WO2005066170A1 (en) | 2003-12-29 | 2005-07-21 | 3M Innovative Properties Company | Arylalkenyl and arylalkynyl substituted imidazoquinolines |
JP2007517044A (ja) | 2003-12-30 | 2007-06-28 | スリーエム イノベイティブ プロパティズ カンパニー | イミダゾキノリニル、イミダゾピリジニル、およびイミダゾナフチリジニルスルホンアミド |
AU2005228150A1 (en) | 2004-03-24 | 2005-10-13 | 3M Innovative Properties Company | Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines |
US8017779B2 (en) | 2004-06-15 | 2011-09-13 | 3M Innovative Properties Company | Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines |
US8026366B2 (en) | 2004-06-18 | 2011-09-27 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines |
US8541438B2 (en) | 2004-06-18 | 2013-09-24 | 3M Innovative Properties Company | Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines |
US7897609B2 (en) | 2004-06-18 | 2011-03-01 | 3M Innovative Properties Company | Aryl substituted imidazonaphthyridines |
WO2006065280A2 (en) | 2004-06-18 | 2006-06-22 | 3M Innovative Properties Company | Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods |
EP1831226B1 (en) | 2004-12-30 | 2012-08-08 | 3M Innovative Properties Company | Chiral tetracyclic compounds inducing interferon biosynthesis |
JP5313502B2 (ja) | 2004-12-30 | 2013-10-09 | スリーエム イノベイティブ プロパティズ カンパニー | 置換キラル縮合[1,2]イミダゾ[4,5−c]環状化合物 |
US9248127B2 (en) | 2005-02-04 | 2016-02-02 | 3M Innovative Properties Company | Aqueous gel formulations containing immune response modifiers |
ES2475728T3 (es) | 2005-02-09 | 2014-07-11 | 3M Innovative Properties Company | Tiazoloquinolinas y tiazolonaftiridinas sustituidas con alcoxi |
AU2006338521A1 (en) | 2005-02-09 | 2007-10-11 | Coley Pharmaceutical Group, Inc. | Oxime and hydroxylamine substituted thiazolo(4,5-c) ring compounds and methods |
CA2597587A1 (en) | 2005-02-11 | 2006-08-17 | Coley Pharmaceutical Group, Inc. | Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods |
AU2006216997A1 (en) | 2005-02-11 | 2006-08-31 | Coley Pharmaceutical Group, Inc. | Substituted imidazoquinolines and imidazonaphthyridines |
JP2008543725A (ja) | 2005-02-23 | 2008-12-04 | コーリー ファーマシューティカル グループ,インコーポレイテッド | ヒドロキシアルキル置換イミダゾキノリン |
JP2008531567A (ja) | 2005-02-23 | 2008-08-14 | コーリー ファーマシューティカル グループ,インコーポレイテッド | ヒドロキシアルキル置換イミダゾキノリン化合物および方法 |
EP1850849A2 (en) | 2005-02-23 | 2007-11-07 | Coley Pharmaceutical Group, Inc. | Method of preferentially inducing the biosynthesis of interferon |
AU2006232377A1 (en) | 2005-04-01 | 2006-10-12 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridine-1,4-diamines and analogs thereof |
JP2008538550A (ja) | 2005-04-01 | 2008-10-30 | コーリー ファーマシューティカル グループ,インコーポレイテッド | ウイルス感染および腫瘍性疾患を処置するためのサイトカイン生合成の調節因子としての1−置換ピラゾロ(3,4−c)環状化合物 |
ZA200803029B (en) | 2005-09-09 | 2009-02-25 | Coley Pharm Group Inc | Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods |
EA200800782A1 (ru) | 2005-09-09 | 2008-08-29 | Коли Фармасьютикал Груп, Инк. | ПРОИЗВОДНЫЕ АМИДА И КАРБАМАТА N-{2-[4-АМИНО-2-(ЭТОКСИМЕТИЛ)-1Н-ИМИДАЗОЛО[4,5-c]ХИНОЛИН-1-IL]-1,1-ДИМЕТИЛЭТИЛ}МЕТАНСУЛЬФОНАМИДА И СПОСОБЫ |
ES2429170T3 (es) | 2005-11-04 | 2013-11-13 | 3M Innovative Properties Company | 1H-Imidazoquinolinas sustituidas con hidroxilo y alcoxilo y métodos |
EP1988896A4 (en) | 2006-02-22 | 2011-07-27 | 3M Innovative Properties Co | CONJUGATES TO MODIFY IMMUNE REACTIONS |
WO2007106854A2 (en) | 2006-03-15 | 2007-09-20 | Coley Pharmaceutical Group, Inc. | Hydroxy and alkoxy substituted 1h-imidazonaphthyridines and methods |
US7906506B2 (en) | 2006-07-12 | 2011-03-15 | 3M Innovative Properties Company | Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods |
WO2008030511A2 (en) | 2006-09-06 | 2008-03-13 | Coley Pharmaceuticial Group, Inc. | Substituted 3,4,6,7-tetrahydro-5h, 1,2a,4a,8-tetraazacyclopenta[cd]phenalenes |
US8709445B2 (en) | 2007-07-31 | 2014-04-29 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Vaccination with killed but metabolically active (KBMA) protozoans with toll-like receptor agonists |
KR101346197B1 (ko) | 2009-07-17 | 2014-02-06 | 한림대학교 산학협력단 | 리포좀에 포집된 올리고뉴클레오타이드 및 에피토프를 포함하는 면역증강용 조성물 |
JP2013500017A (ja) * | 2009-07-24 | 2013-01-07 | カッパーアールエヌエー,インコーポレイテッド | サ−チュイン(sirt)への天然アンチセンス転写物の阻止によるサ−チュイン(sirt)関連疾患の治療 |
PT2606047T (pt) | 2010-08-17 | 2017-04-07 | 3M Innovative Properties Co | Composições, formulações e métodos de um composto lipidado modificador da resposta imunitária |
BR112013031039B1 (pt) | 2011-06-03 | 2020-04-28 | 3M Innovative Properties Co | compostos de hidrazino 1h-imidazoquinolina-4-aminas, conjugados feitos destes compostos, composição e composição farmacêutica compreendendo ditos compostos e conjugados, usos dos mesmos e método de fabricação do conjugado |
CA2838158C (en) | 2011-06-03 | 2019-07-16 | 3M Innovative Properties Company | Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom |
US9228184B2 (en) | 2012-09-29 | 2016-01-05 | Dynavax Technologies Corporation | Human toll-like receptor inhibitors and methods of use thereof |
US9868955B2 (en) | 2012-09-29 | 2018-01-16 | Dynavax Technologies Corporation | Human toll-like receptor inhibitors and methods of use thereof |
US10654807B2 (en) | 2013-12-20 | 2020-05-19 | The University Of Kansas | Toll-like receptor 8 agonists |
WO2017038909A1 (en) * | 2015-08-28 | 2017-03-09 | Takeda Pharmaceutical Company Limited | Heterocyclic compounds |
CA3086439A1 (en) | 2017-12-20 | 2019-06-27 | 3M Innovative Properties Company | Amide substitued imidazo[4,5-c]quinoline compounds with a branched chain linking group for use as an immune response modifier |
US11365413B2 (en) * | 2018-08-22 | 2022-06-21 | Board Of Regents, The University Of Texas System | Inhibition of poly(A) binding protein and the treatment of pain |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030139364A1 (en) * | 2001-10-12 | 2003-07-24 | University Of Iowa Research Foundation | Methods and products for enhancing immune responses using imidazoquinoline compounds |
AU2003230806B2 (en) * | 2002-04-04 | 2009-05-07 | Zoetis Belgium S.A. | Immunostimulatory G,U-containing oligoribonucleotides |
US7387271B2 (en) * | 2002-12-30 | 2008-06-17 | 3M Innovative Properties Company | Immunostimulatory combinations |
EP1592302A4 (en) * | 2003-02-13 | 2007-04-25 | 3M Innovative Properties Co | METHODS AND COMPOSITIONS ASSOCIATED WITH IMMUNE RESPONSE MODIFIER COMPOUNDS AND TOLL-LIKE RECEPTOR 8 |
US8940755B2 (en) * | 2003-12-02 | 2015-01-27 | 3M Innovative Properties Company | Therapeutic combinations and methods including IRM compounds |
-
2005
- 2005-12-08 WO PCT/US2005/044448 patent/WO2006063152A2/en active Application Filing
- 2005-12-08 JP JP2007545629A patent/JP2008523084A/ja not_active Withdrawn
- 2005-12-08 US US11/720,872 patent/US20100113565A1/en not_active Abandoned
- 2005-12-08 EP EP05853384A patent/EP1819226A4/en not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2008523084A5 (ja) | ||
JP2008523076A5 (ja) | ||
ZA200802892B (en) | Vaccines and methods to treat canine influenza | |
IL245489A0 (en) | New 1-aryl-3-azabicyclo[0.1.3]hexanes, their preparation and their use for the treatment of neuropsychotic disorders | |
BRPI0811473A2 (pt) | Compostos hidrossolúveis de magnésio como agentes de limpeza e métodos de utilização dos mesmos. | |
IL188420A0 (en) | Methods and compositions with enhanced therapeutic activity | |
BRPI0720178A2 (pt) | Derivados de 2,3-di-hidroimidazo[1,2-c]quinazolina substituída úteis para tratar distúrbios e doenças hiperproliferativos associados com angiogênese | |
BRPI0819533A2 (pt) | Microorganismos para melhorar o estado de saúde de indivíduos com desordens relacionadas com a ingestão de glúten | |
EP1888765A4 (en) | METHOD AND COMPOSITIONS FOR DIAGNOSIS OF VENOUS THROMBOEMBOLIC ILLNESSES | |
IL186616A (en) | Spyro-oxa-indoles and their use as drugs | |
BRPI0719930A2 (pt) | Produtos de limpeza com habilidades de limpeza melhoradas | |
BRPI0719995A2 (pt) | Composições e métodos para tratar distúrbios musculares & cardiovasculares | |
CL2007002837A1 (es) | Uso de fenitoina para tratar mucositis oral. | |
HK1157341A1 (en) | Pyrimidine derivative having cell-protecting activity and use thereof | |
EP2311936A4 (en) | NOVEL MICROORGANISM AND AGENT FOR CONTROLLING PLANT DISEASES USING MICROORGANISM | |
HK1118804A1 (en) | Novel unsaturated fatty hydroxy acid derivatives and the dermocosmetologic use thereof | |
FR2905600B1 (fr) | Traitement des vertiges par l'acetyl-l-leucine. | |
FR2899254B1 (fr) | Tete de douchette avec dosage de savons, sels et similaires. | |
IL199178A0 (en) | Aminoalcohol derivatives and their therapeutic use | |
CL2007003553A1 (es) | Uso de epotilonas para tratar enfermedades asociadas con un desequilibrio entre la actividad osteoblastica y osteoclastica. | |
BRPI0714307A2 (pt) | Uso de benzamidas trifluormetil-substituídas no tratamento de distúrbios neurológicos | |
IL185575A0 (en) | Benzoxazocines and their therapeutic use | |
FR2904626B1 (fr) | Derives de pyrazolo[4,3]thiazole, leur preparation et leur application en therapeutique | |
EP1986743A4 (en) | USE OF LOW STREAMERS TO INCREASE THE EFFECTIVENESS OF IONIZING RAYS AND OTHER TREATMENTS | |
GB0806669D0 (en) | Animal model with induced arrhythmia |